|
![]() |
|||
|
||||
OverviewAcute coronary syndrome (ACS) continues to challenge our health care system in the complexity of presentation and the ever increasing number of patients exhibiting signs and symptoms of an acute coronary syndrome. Written by leading experts, Short Stay Management of Chest Pain provides scientific and clinical insights on the management of patients who arrive at the hospital with a presentation consistent with a potential acute coronary syndrome. Focusing on the cardiology aspects of chest pain, Short Stay Management of Chest Pain is a valuable tool for acute care physicians, nurses, and hospital administrators devoted to caring for this population. Short Stay Management of Chest Pain details the remarkable improvements in diagnostic accuracy and improved patient outcomes for patients presenting with suspected acute coronary syndromes. Full Product DetailsAuthor: William Franklin Peacock , Christopher P. CannonPublisher: Humana Press Inc. Imprint: Humana Press Inc. Dimensions: Width: 15.50cm , Height: 2.30cm , Length: 23.50cm Weight: 0.642kg ISBN: 9781603279475ISBN 10: 1603279474 Pages: 283 Publication Date: 01 July 2009 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: In Print ![]() Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsI. Introduction 2 Peacock II. Epidemiology and Demographics of Coronary Artery Disease 5 Dadkah III. Financial Impact of Chest Pain 10 Sieck a. US costs b. Economic case for a short stay unit IV. Why have a chest pain unit? 10 Toth a. QI data b. Outcomes data c. Financial aspects V. Pathophysiology and Definition of ACS 10 Amsterdam a. Unstable Angina b. NSTEMI c. STEMI VI. Emergency Department presentation 10 Collins a. Common presentations b. Confounders (gender, age, etc) c. Differential diagnosis d. Guideline recommendations 5 i. ECG time ii. Marker turn around time VII. Risk Stratification Storrow a. History and Physical 5 b. ECG 12 i. 12 lead ii. Future developments c. Cardiac Markers 15 Christianson i. Necrosis markers 1. Troponin I/T 2. CKMB 3. Myoglobin 4. Future developments ii. Ischemia markers 1. Ischemia Modified Albumin 2. Myeloperoxidase (MPO) 3. Future developments iii. Point of care vs lab iv. Confounders 1. Renal failure 2. Recent cardiac procedures 3. Re-infarction v. Panels vi. Future developments d. Scoring systems 10 Hollander i.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |